Devin W. Steenkamp, MBChB

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Devin Steenkamp is Associate Professor of Medicine in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Chobanian and Avedisian School of Medicine, Boston, MA. Dr. Steenkamp is an adult endocrinologist with a particular interest in type 1 diabetes, atypical diabetes phenotypes and diabetes technology. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine. He established the diabetes technology program, with a particular focus on utilizing modern technologies to improve the care and outcomes for underserved adults living with diabetes.

In his clinical leadership role, he is responsible for leading a team of multidisciplinary clinicians with specific expertise in implementing advanced diabetes technologies into care and has overseen the development of various innovative clinical programs. Dr. Steenkamp has also been a leader integral to the advancement of the diabetes clinical research program and has been an investigator on multiple multi-center clinical trials and translational projects, sponsored by the NIH, various foundations and industry sponsors.

Publications

  • Published 7/18/2026

    Iyengar J, Steenkamp D, Rioles N, Roberts A. Response to Letter to the Editor: "Close the Loop: Diabetes Distress Screening Should Be Judged by Response, Not by Completion". Endocr Pract. 2026 Jul 18. PMID: 42471055.

    Read at: PubMed

  • Published 5/19/2026

    Kang JW, Causey J, Steenkamp D, Park S, Heise HM, Weber A, Ntziachristos V, Coutard JG, Kamath A, Barman I, Mäntele W, Jue M, So PTC. Workshop on Noninvasive Glucose Monitoring 2025. J Diabetes Sci Technol. 2026 Jul; 20(4):1472-1479. PMID: 42153588.

    Read at: PubMed

  • Published 1/30/2026

    Iyengar J, Steenkamp D, Abdelhadi M, Berman C, Buckingham D, Coulter M, Hannon TS, Joarder F, Rioles N, Semenkovich K, Tweet R, Vora D, Wolf RM, Yardley H, Roberts A. It Is Time to Act: Making Diabetes Distress Screening Standard in Clinical Practice. Endocr Pract. 2026 Apr; 32(4):670-673. PMID: 41621645.

    Read at: PubMed

  • Published 12/10/2025

    Seen M, Llevenes P, Kang H, Qiu Y, Ennis C, Chen A, Alexanian S, Steenkamp D, Monti S, Denis GV. Metabolic medications modify prostate cancer progression through exosome reprogramming. bioRxiv. 2025 Dec 10. PMID: 41415378.

    Read at: PubMed

  • Published 11/14/2025

    Levy CJ, Kanapka L, Brown SA, Marks S, Spaic T, Steenkamp DW, Lu VS, Zhao P, Lum JW, Beck RW, Pinsker JE. Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2026 May; 28(5):501-508. PMID: 41264341.

    Read at: PubMed

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Education

  • University of Pretoria, MBChB